COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.
J Stroke Cerebrovasc Dis
; 30(7): 105822, 2021 Jul.
Article
in English
| MEDLINE | ID: covidwho-1179851
ABSTRACT
There have been limited cases linking SARS-CoV-2 infection with the development of reversible cerebral vasoconstriction syndrome (RCVS). We hereby report a rare case of RCVS in the setting of mild SARS-CoV-2 respiratory infection successfully treated with nimodipine and aspirin. SARS-CoV-2 attacks the ACE2-receptors, which are expressed in various body organs including the lungs, kidneys, and blood vessels. Vasoconstriction can result from down-regulation of the ACE2-receptors that can lead to sympathetic hypertonia of the cerebral blood vessel walls and/or over-activation of the renin-angiotensin axis.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vasoconstriction
/
Vasodilator Agents
/
Nimodipine
/
Cerebral Arteries
/
Aspirin
/
Vasospasm, Intracranial
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
J Stroke Cerebrovasc Dis
Journal subject:
Vascular Diseases
/
Brain
Year:
2021
Document Type:
Article
Affiliation country:
J.jstrokecerebrovasdis.2021.105822
Similar
MEDLINE
...
LILACS
LIS